NovoCure Ltd. Release: Clinical Trial for Newly Diagnosed Glioblastoma Opened in Korea
5/7/2013 9:07:28 AM
More...
|
NovoCure Ltd. Presents Preclinical Data at the American Association for Cancer Research
4/10/2013 7:18:32 AM
More...
|
NovoCure Ltd. Release: NCCN Guidelines® Recommend NovoTTF™ Therapy as a Standard Treatment Option for CNS Cancers
1/22/2013 10:34:56 AM
More...
|
NovoCure Ltd. Appoints Four New Independent Members to its Board of Directors
1/8/2013 12:08:48 PM
More...
|
NovoCure Ltd. Release: New Data on NovoTTF™ Therapy to be Presented at the 2012 SNO Meeting
11/14/2012 10:22:37 AM
More...
|
NovoCure Ltd. Release: Galien Foundation Selects NovoTTF™-100A System as a Finalist for the Prix Galien USA Award
8/10/2012 10:38:01 AM
More...
|
NovoCure Ltd. to Present NovoTTF(TM) Therapy Data at the 2012 Annual Scientific Meeting of the American Society of Clinical Oncology
5/30/2012 10:01:30 AM
More...
|
NovoCure Ltd. Certifies Eight Additional Clinical Centers of Excellence to Treat Most Common Brain Tumor with Tumor Treating Fields (TTFields) Therapy
5/25/2012 9:54:36 AM
More...
|
Study Results of NovoCure Ltd.'s NovoTTF(TM) Pivotal Phase 3 Trial Published in European Journal of Cancer
5/22/2012 10:14:23 AM
More...
|
NovoCure Ltd. Announces Launch of Recurrent Glioblastoma Product Website
5/15/2012 9:53:35 AM
More...
|
|